Moderna, Inc. (MRNA)

70.56
4.80 7.30
NASDAQ
Prev Close 65.74
Open 68.35
Day Low/High 66.23 / 74.54
52 Wk Low/High 15.52 / 95.21
Volume 13.71M
Exchange NASDAQ
Shares Outstanding 394.59B
Market Cap 27.89B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.

The Investment Angle of Covid-19

The Investment Angle of Covid-19

Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

I see no reason to flee this name, therefore, I am not.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

What's Happening Now Is a Change in Institutional Investor Mindset

What's Happening Now Is a Change in Institutional Investor Mindset

Being scared of a pullback isn't 'expensive' or 'stupid'. It's just good investing.

Stock-Specific Ideas for the Post-Fed Era of Investing

Stock-Specific Ideas for the Post-Fed Era of Investing

Make sure that your portfolio is composed of sane assets for the balance of this crazy year.

How About That Merck and Seattle Genetics Deal?

How About That Merck and Seattle Genetics Deal?

I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Also, several scheduled events this week, election risk, earnings to watch.

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

This writer is rooting for the success of all efforts to halt the spread of the virus as he struggles with the aftereffects of the disease.

Moderna and AstraZeneca Could Use a Shot in the Arm

Moderna and AstraZeneca Could Use a Shot in the Arm

An effective Covid-19 will be a game-changer, but charts say the bottom-line impact may not be as significant as previously believed.

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Plus, reading tea leaves in the recent action in Apple and Salesforce.com.

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Plus, Veeva Systems reports stellar results and ups its guidance.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'

Mitch's Hurtful Words, Tuesday's Tumble, Do-Nothing Congress: Market Recon

Mitch's Hurtful Words, Tuesday's Tumble, Do-Nothing Congress: Market Recon

Plus, quick looks at Joe Biden's VP choice, the latest on the Covid-19 vaccine front and Tesla's stock split.

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

Markets may believe that we are closer to the effective use of vaccines and therapeutics than we know in this battle against Covid-19.

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

The whole group has run and the guidance from Clorox does show, more than anything, that nobody knows.

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.